M&A Deal Summary |
|
|---|---|
| Date | 2024-11-14 |
| Target | aixigo |
| Sector | Software |
| Buyer(s) | Amundi Private Equity |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| PE ASSETS | 1.0B EUR |
| Size | Large |
| Type | Sector Agnostic |
Amundi Private Equity is the direct, private equity investment arm of asset manager Amundi. The Group looks to invest €10 to €50 million in growth companies generating up to €1.5 billion in sales. Amundi Private Equity principally looks to acquire stakes in French companies, but will consider broader Western Europe as well. Sectors of interest include financial services, healthcare, materials, consumer products, energy, information technology, and communications. Amundi Private Equity is based in Paris, France.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 17 |
| Sector: Software M&A | 3 of 3 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 3 of 3 |
| Country: Germany M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-10-30 |
CBA
Avignon, France CBA is a provider of billing and patient management software for private sector nurses in France with more than 28,000 subscribers. CBA's software is essential to the daily activities of private sector nurses and covers both medical functions (e.g. patient management, remote transmission of patient records to social security) as well as administrative functions (e.g. scheduling, accounting, health insurance payment collection). CBA was founded in 1986 and is based in Avignon. France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-11-21 |
Deenova
Gragnano Trebbiense, Italy Deenova is a provider of advanced services to hospitals. It offers integrated turn-key solutions to hospitals for the traceability and management of unit dose drugs and medical devices. Deenova solutions, which include proprietary software, patented robotic technologies and specialist support services, enable drugs and medical devices management from digital prescription to automated personalized unit dose treatment, up to software controlled administration to patients. Complete traceability of medications and medical devices allows significant reduction in errors in therapy management and in related waste, resulting in material savings for hospitals in terms of reduced drug spending and clinical risk. Deenova was founded in 2004 and is based in Gragnano Trebbiense, Italy. |
Buy | - |
